W.I.S.E. CSI 300 china tracker (02827.HK) Rises 0.72% in Afternoon Trade, AUM at HKD 886 Million
NewTimeSpace News: As of 14:51 on June 17, 2026, W.I.S.E. CSI 300 china tracker (02827.HK) advanced 0.72%, trading at HKD 50.160. The ETF recorded a volume of 100,400 shares, a turnover of HKD 5.018 million, and an average price of HKD 49.980. The current Net Asset Value (NAV) stood at HKD 49.750, with total Assets Under Management (AUM) of HKD 886 million, total shares issued of 17.8 million, and a board lot size of 200 shares per hand.
W.I.S.E. CSI 300 china tracker (02827.HK) tracks the CSI 300 Index. Its constituents are 300 A-share companies with the largest market capitalization and highest liquidity listed on the Shanghai and Shenzhen Stock Exchanges.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- W.I.S.E. CSI 300 china tracker (02827.HK) Rises 2.00% Intraday, Turnover at HKD 9.6289 Million
- W.I.S.E. CSI 300 china tracker(02827.HK) Falls 0.54% Intraday, NAV Per Unit at HK$48.242
- W.I.S.E. CSI 300 china tracker(02827.HK) Dips 1.53% in Afternoon Trading, NAV at HK$48.902
- CONTEL(01912.HK) closed 15.38% lower on Jun 17, the Hang Seng Semiconductors Sector saw divergent trends
- Henlius(02696.HK): HLX3902 Injection (STEAP1xCD3xCD28 Trispecific Antibody) Gets NMPA Approval for Phase I Clinical Trial in Metastatic Castration-Resistant Prostate Cancer